文献速递心境障碍

普通人群代谢组全关联研究揭示抑郁者血清月桂酰肉碱水平降低

A metabolome-wide association study in the general population reveals decreased levels of serum laurylcarnitine in people with depression.
PubMed 文献 · Mol Psychiatry · 2021-06-04

在KORA F4研究的1411名参与者中,采用线性回归分析353种血清代谢物与抑郁情绪(DM)的关联,发现月桂酰肉碱水平显著降低,并在SHIP-Trend研究的968名参与者中独立重复验证。该关联在按性别、自杀意念和抗抑郁药使用分层的亚组中仍显著。

要点

  • 抑郁情绪与血清月桂酰肉碱水平降低显著相关。
  • 该发现在独立队列SHIP-Trend中成功重复验证。
  • 关联在性别、自杀意念及抗抑郁药使用亚组中稳定。

核心结论

  • 抑郁个体血清月桂酰肉碱水平降低,可能提示脂肪酸氧化受损和/或线粒体功能障碍。

研究设计与样本

  • 在KORA F4研究的1411名参与者(发现队列)中开展代谢组全关联分析,检测353种独特血清代谢物。
  • 在SHIP-Trend研究的968名参与者(重复队列)中进行独立重复验证。

主要发现

  • KORA F4队列中72名(5.1%)参与者存在抑郁情绪。
  • 经Benjamini/Hochberg多重检验校正后,抑郁情绪与月桂酰肉碱水平显著降低相关。
  • 该发现在SHIP-Trend队列(52名抑郁个体,占5.4%)中重复验证。
  • 按性别、自杀意念和抗抑郁药使用分层的亚组中,月桂酰肉碱与抑郁的关联保持显著(p值<0.05)。

临床怎么用

  • 血清月桂酰肉碱水平降低可能作为抑郁障碍的潜在生物标志物。
  • 该发现提示脂肪酸氧化和/或线粒体功能可能成为抑郁障碍的新治疗靶点。

局限性

  • 原文未报告代谢组全关联分析的多重检验校正具体阈值或效应量。
  • 原文未报告研究设计为横断面或纵向,无法推断因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Depression constitutes a leading cause of disability worldwide. Despite extensive research on its interaction with psychobiological factors, associated pathways are far from being elucidated. Metabolomics, assessing the final products of complex biochemical reactions, has emerged as a valuable tool for exploring molecular pathways. We conducted a metabolome-wide association analysis to investigate the link between the serum metabolome and depressed mood (DM) in 1411 participants of the KORA (Cooperative Health Research in the Augsburg Region) F4 study (discovery cohort). Serum metabolomics data comprised 353 unique metabolites measured by Metabolon. We identified 72 (5.1%) KORA participants with DM. Linear regression tests were conducted modeling each metabolite value by DM status, adjusted for age, sex, body-mass index, antihypertensive, cardiovascular, antidiabetic, and thyroid gland hormone drugs, corticoids and antidepressants. Sensitivity analyses were performed in subcohorts stratified for sex, suicidal ideation, and use of antidepressants. We replicated our results in an independent sample of 968 participants of the SHIP-Trend (Study of Health in Pomerania) study including 52 (5.4%) individuals with DM (replication cohort). We found significantly lower laurylcarnitine levels in KORA F4 participants with DM after multiple testing correction according to Benjamini/Hochberg. This finding was replicated in the independent SHIP-Trend study. Laurylcarnitine remained significantly associated (p value < 0.05) with depression in samples stratified for sex, suicidal ideation, and antidepressant medication. Decreased blood laurylcarnitine levels in depressed individuals may point to impaired fatty acid oxidation and/or mitochondrial function in depressive disorders, possibly representing a novel therapeutic target.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Zacharias HU, Hertel J, Johar H, et al. A metabolome-wide association study in the general population reveals decreased levels of serum laurylcarnitine in people with depression. Mol Psychiatry. 2021. PMID: 34088979. doi:10.1038/s41380-021-01176-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。